| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Sodium iodohippurate[131I]7.4MBq/1mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| 6-[131I]Iodomethylnorcholesterol 37 MBq/ml, injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Product containing xenon-133 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| xenon[133Xe] 74-185 MBq/ml i cylinderampul med saltvand til injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| xenon[133Xe] 74-1480 MBq/ml gascylinderampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| xenon[133Xe] 925-7400 MBq/ml flerdosis-gasbeholder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| radioisotopgeneratorer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium-99m-generator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| indium[113In]-generator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| krypton[81m]-generator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-fanolesomab injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| midler og kits til billeddiagnostik af lunger |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-depreotid injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-arcitumomab injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| natriumiodid[131I] 37-7400 MBq behandlingskapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| phosphor-32 (diagnostisk) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| xenon[133Xe] 925-5550MBq/m gasampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| xenon[133Xe] 60-2480 MBq/ml gasampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| xenon[133Xe] 555 MBq/ml i cylinderampul med saltvand til injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| diagnostisk radioisotop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| indium^113^-chlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| terapeutisk radioisotop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Product containing iodine-131 (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-svovlkolloid injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| yttrium-chlorid [90Y] prækursoropløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| cobaltchlorid, co-57 0,012 ml/opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| cobaltchlorid, co-57 0,012 ml kapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| ioderet albumin ^125^I, serum, 10 mg, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| natriumiodid[131I] 37-7400 MBq pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| 6-[131I]Iodomethylnorcholesterol 8-30 MBq/ml, pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| kromphosphat[32P] 185 MBq/ml pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| rhenium[186Re]-etidronat 1,3 GBq/ml pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| kromchloridhexahydrat 4 µg/ml injektionsvæske, opløsning, hætteglas a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Phosphocol, p-32 15 mCi injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| kromphosphat, p-32 15 mCi injektionsvæske, suspension, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| kromchloridhexahydrat 4 µg/ml injektionsvæske, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-rheniumsulfid-kolloid injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-albuminkolloid (nanostørrelse) injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-disofenin injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] etifenin injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-mebrofenin injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] tin pyrophosphate injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] albumin injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] microspheres injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-teboroxim injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-sestamibi injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-tetrofosmin injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-mertiatid injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] pentetate injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-glucoheptonat injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-gluconat injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] succimer injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| [99mTc]Technetium-ethylcysteinat-dimer, til injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-exametazim injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Sodium pertechnetate[99mTc]fission injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] macrosalb injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-oxidronat injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-albumin-millimikrosfærer injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Technetium[99mTc] tin colloid injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-albuminkolloid injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| technetium[99mTc]-humant immunglobulin G injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Radiopharmaceutical poisoning |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Accidental radiopharmaceutical poisoning |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Intentional radiopharmaceutical poisoning |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| forgiftning med radiofarmaceutisk middel, uvist med hvilken hensigt |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Contrast media (substance) |
Is a |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| overdosis af radiofarmaceutisk middel, uvist med hvilken hensigt |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Radiopharmaceutical adverse reaction |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Accidental radiopharmaceutical overdose |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Radiopharmaceutical overdose |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Intentional radiopharmaceutical overdose |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Ioflupane (123-I) (substance) |
Is a |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| Iobenguane |
Is a |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
|
| radiofarmaceutisk billeddiagnostisk undersøgelse |
Using substance (attribute) |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| radiofarmaceutisk billeddiagnostisk undersøgelse |
Using substance (attribute) |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intraarterial route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intraarticular route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intravenous route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intracavitary route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intraarterial route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intraarticular route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intracavitary route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Administration of radiopharmaceutical agent via intravenous route (procedure) |
Direct substance |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
| Allergy to radiopharmaceutical |
Causative agent |
False |
radiofarmaceutisk middel |
Inferred relationship |
Some |
1 |
FHIR